Sobre

Hello! I need a female voiceover artist (Brittish accent) for an urgent project. NO AI voiceovers. Please share your corporate samples. This will be the full text:: At Access Infinity, we’re building the digital infrastructure layers that help market access teams achieve excellence globally. Our category-defining suite of digital solutions, Nuro, Access Hub and Evidence Hub is revolutionising the way market access leaders gather payer insights, track product launches, and manage evidence. Probably why the world’s largest pharma companies trust us with their business… And why we’ve seen 20 percent growth year-on-year. So what sets us apart from any other digital solution in the space? To demonstrate, let’s dive into one of our most powerful products yet, Nuro. An AI-powered business intelligence tool that helps market access leaders find game-changing insights faster than ever before. Trained on over 1.5 million data points, Nuro connects a wider breadth of factors influencing price than any competitor in the market. Making it the only solution that allows clients to filter through more than 450 data points for each drug. And when combined with our AI capabilities… …clients can easily get answers to their most complicated pricing and reimbursement questions. Compressing projects that usually take weeks, to a matter of minutes And that’s just the tip of the iceberg. With its deep data foundations, integrated analytics engine layered with Gen AI, Nuro has been designed to be big. Really big. Providing value to end users at every stage of drug development. This means that there are many ways Nuro can fit into a client’s workflow. That’s why we’ve done the work to deeply understand the needs of different archetypes of market access users and segmented them into four specific personas… … each with a distinct set of pain points and metrics for success. Nuro’s product roadmap is focussed on systematically dominating in each persona segment, By providing far more targeted value than other providers. For example, with Early Access Personas, one of the key benchmarks of success is being able to evaluate payer evidence gaps and forecast net prices. So when we built Nuro, we made sure it could bring together comprehensive data sets on price, HTAs and evidence in an intuitive UI. The end result? Nuro has become the dominant tool of choice for this persona group, rated far above competitor products like Navlin or GPI. Making it the trusted tool for early market access teams in Pfizer, Eli Lilly and Astra Zeneca to name a few. And Nuro’s impact doesn’t stop there. Its intelligence powers Access Hub and Evidence Hub too, creating a seamless ecosystem for Market Access teams. Just one of the many ways Access Infinity is leading the pack in Market Access.